Healthcare
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
15% of Americans have ever taken the drugs, up from 6% in 2024.
Phrase
Glp-1 weight
No market stories in the last 7 days. The latest coverage is below.
- 7-day mood
- —Not enough data
- Stories, 7 days
- 0
- Last 24 hours
- 0no baseline yet
- Sources
- 3in the latest 3
Mood and coverage · last 7 days
Market chart- Glp-1 weight · 6-hour average
- Hourly reading
- Stories per hour
No scored stories in the last 7 days.
View as table
| Day | Mood | Stories |
|---|---|---|
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
| Fri, Oct 2 | — | 0 |
Latest on Glp-1 weight
Newest firstHealthcare
Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
What you should know about the federal government's pilot program offering GLP-1s solely for weight loss.
Healthcare
2026 will bring more GLP-1 weight loss pills - and new habits. These stocks are poised to benefit
Novo Nordisk and Eli Lilly are expected to bring GLP-1 pills to market in the new year, which is expected to boost the number being treated.
